Market access and value-based pricing of digital health applications in Germany

Gensorowsky, Daniel; Witte, Julian; Batram, Manuel; Greiner, Wolfgang

doi:10.1186/s12962-022-00359-y

Cost Effectiveness and Resource Allocation

Table 1 General characteristics and prices of DiGA listed in the DiGA directory (as of 02/28/2022).

From: Market access and value-based pricing of digital health applications in Germany

DiGA-Name	Indication(s)	Primary intervention principle(s)	Date of listing	Listing status (initial / current)	pVE^a	Application type	Prescription period	MP^b per prescription	NP^c per prescription (discount on MP)
Kalmeda	Tinnitus	CBT	09/25/2020	P / F	MB	App	90 days	203.97 €	–
velibra	Generalized anxiety Disorder, Panic disorder (with/without agoraphobia), Social phobias	CBT	10/01/2020	F	MB, PSVV	Browser	90 days	476.00 €	–
somnio	Insomnia	CBT	10/22/2020	F	MB	App, Browser	90 days	464.00 €	224.99 € (–52 %)
Vivira	Back pain	Physiotherapy	10/22/2020	P / F	MB	App	90 days	239.96 €	–
zanadio	Obesity	multimodal obesity therapy	10/22/2020	P / P	MB	App	90 days	499.80 €	–
Invirto	Agoraphobia, Panic disorder, Social phobias	CBT	12/03/2020	P / P	MB	App	90 days	620.00 € (incl. VR glasses)	–
elevida	Fatigue in multiple sclerosis	CBT	12/15/2020	F	MB	Browser	90 days	743.75 €	–
M-sense Migräne	Migraine	Headache diary, Prophylaxis exercises	12/16/2020	P / P	MB, PSVV	App	90 days	219.98 €	–
Selfapys Online-Kurs bei Depression	Depression	CBT	12/16/2020	P / P	MB	Browser	90 days	540,00 €	–
Rehappy	Stroke	Motivation, Education	12/29/2020	P / P	MB, PSVV	App, Browser	90 days	Initial prescription: 449,00 € (incl. energy band) Follow-up: 299.00 €	–
deprexis	Depression	CBT	02/20/2021	F	MB	Browser	90 days	297.50 €	–
Mika	Cancer	Symptom Documentation, Education	03/25/2021	P / P	MB	App	90 days	499.00 €	–
Mindable	Agoraphobia, Panic disorder	CBT	04/29/2021	P / P	MB, PSVV	App	90 days	576.00 €	–
CANKADO PRO-React Onco	Breast cancer	Symptom documentation	05/03/2021	P / P	PSVV	App, Browser	90 days	499.80 €	–
vorvida	Harmful alcohol Consumption, alcohol Dependence	CBT	05/06/2021	F	MB, PSVV	Browser	90 days	476.00 €	–
Selfapys Online-Kurs bei Generalisierter Angststörung	Generalized anxiety disorder	CBT	06/19/2021	P / P	MB	Browser	90 days	540.00 €	–
Selfapys Online-Kurs bei Panikstörung	Panic disorder	CBT	06/19/2021	P / P	MB	Browser	90 days	540.00 €	–
NichtraucherHelden-App	Tobacco dependence	CBT	07/03/2021	P / P	MB	App	90 days	Initial prescription: 239.00 € Follow-up: 99.00 €	–
ESYSTA App & Portal	Diabetes	Diabetes diary	07/04/2021	P / P	MB	App, Browser	90 days	249.86 €	–
Mawendo	Knee pain	Physiotherapy	08/09/2021	P / P	MB	Browser	One-time license	119.00 €	–
Oviva Direkt für Adipositas	Obesity	Multimodal Obesity therapy	10/03/2021	P / P	MB	App	90 days	345.00 €	–
companion patella	Knee pain	Physiotherapy	10/04/2021	P / P	MB	Browser	90 days	345.10 €	–
Novego	Depression	CBT	10/10/2021	P / P	MB	Browser	90 days	249.00 €	–
HelloBetter Stress und Burnout	Stress, burnout	CBT	10/18/2021	F	MB	Browser	90 days	599.00 €	–
HelloBetter Diabetes und Depression	Depression in diabetes mellitus	CBT	12/11/2021	F	MB	Browser	90 days	599.00 €	–
Kranus Edera	Impotence of organic origin	Physical training, Psychotherapy, mindfulness and sexual therapy	12/18/2021	P / P	MB, PSVV	App	90 days	656.88 €	–
HelloBetter ratiopharm chronischer Schmerz	Chronic pain	CBT	12/18/2021	P / P	MB	Browser	90 days	599.00 €	–
Cara Care für Reizdarm	Irritable bowel syndrome	CBT, dietary support	12/26/2021	P / P	MB, PSVV	App	90 days	718.20 €	–
HelloBetter Vaginismus Plus	Vaginismus	CBT	02/04/2022	F	MB	Browser	90 days	599.00 €	–
neolexon Aphasie	Aphasia, apraxia	Logopedic training	02/06/2022	P / P	MB	App, browser	90 days	487.90 €	–

CBT: cognitive behavioural therapy; MB: medical benefit; MP: freely-set manufacturer price; NP: negotiated price; pVE: positive Versorgungseffekte (positive healthcare effects); pSVV: patientenrelevante Struktur- und Verfahrensverbesserungen in der Versorgung (patient-relevant improvements of structure and processes); P: provisional; F: final
^aFor DiGA with provisional listing (i.e., whose study results are not yet available), study design and postulated benefit are stated as described in the DiGA directory.
^bRepresents the current freely-set manufacturer price or, if the manufacturer price has already been replaced by a negotiated price, the last valid manufacturer price before the negotiated price came into effect.
^cIncludes negotiated prices and prices set by the arbitration board, which replace the freely-set manufacturer prices by the 13th month after listing in the DiGA directory.

Back to article page

ISSN: 1478-7547

Contact us

General enquiries: journalsubmissions@springernature.com